The Ministry of Food and Drug Safety announced a three-month manufacturing suspension for Celltrion Pharm's Astection Enteric Coated Tablets 100mg (aspirin), effective from Feb. 27 to May 26, due to violations of the Pharmaceutical Affairs Act.The medication is used for preventing thrombosis in cond
On Monday, trainee doctors at Korea’s so-called “Big 5” hospitals submitted a wave of resignations, despite the government’s threat to suspend their medical licenses if they do not return to work.The five largest hospitals are Seoul National University Hospital, Samsung Medical Center, Asan Medical
Seegene, once hailed as a beneficiary of the Covid-19 pandemic, has reported a significant deterioration in profitability due to a drastic decline in related sales as the world transitions to the endemic phase of the virus.The company announced its preliminary financial results for 2023 last Friday,
VUNO said it has entered into a strategic partnership with DRGEM to embed VUNO's advanced AI solutions into DRGEM's X-ray systems.Under the agreement, VUNO will supply its AI-based thoracic X-ray interpretation assistant solution, VUNOMED Chest X-ray, to DRGEM.VUNOMED Chest X-ray stands out as an AI
In recent years, Korea's market for pediatric growth hormone treatments has witnessed a significant surge, with non-reimbursable treatments accounting for 90 percent of the total prescriptions. According to IQVIA, a drug market research firm, the pediatric growth hormone treatment market grew to 238
A research team at Yongin Severance Hospital has demonstrated the effectiveness of ChatGPT, specifically the GPT-4 model, in accurately predicting cardiovascular diseases.GPT-4, the latest iteration of the ChatGPT series developed by OpenAI, has previously garnered attention for passing the United S
Daewoong Pharmaceutical's Fexuclue is expanding globally as fast as it is effective.Daewoong said Friday that its gastroesophageal reflux disease (GERD) treatment, Fexuclue, has entered or is about to enter the market in 24 countries, including Korea, in just one year and six months since its launch
Lunit announced a record-breaking revenue of 25 billion won ($21 million) for 2023, marking an 80.9 percent increase from 13.8 billion won a year earlier, thanks to a continued expansion of overseas sales of medical AI solutions. Last year, the Kosdaq-listed company posted an operating loss of appro
In a controversial move, the Korean government announced a plan to increase the admission quota for medical schools by 2,000 students on Feb. 6, sparking fierce opposition from the medical community, including the Korean Medical Association (KMA) and other healthcare organizations.The medical commun
Celltrion is expanding its market presence in Peru, a key Latin American market, with successful public tender wins.Celltrion’s Truxima 500mg (rituximab) won the tender for the Peruvian Ministry of Health (Centro Nacional de Abastecimiento de Recursos Estratégicos en Salud, CENARES), the largest pub
Dong-A ST and IMBiologics said they have entered into a research collaboration agreement to develop a novel antibody drug candidate.The collaboration involves IMBiologics deploying its ePENDY (enhanced/engineered Pentamer body) platform technology.Unlike the conventional IgG antibody-based modalitie
Korean bio ventures are increasingly withdrawing their initial public offerings (IPOs) voluntarily after the stock market regulator Korea Exchange (KRX) has taken steps to implement a more rigorous review process.Most recently, Pinotbio voluntarily withdrew its Kosdaq listing plan on Wednesday, nine
SK chemicals said that it has decided not to proceed with the sale of its pharmaceutical business unit despite having previously signed a non-binding memorandum of understanding (MOU) with Glanwood Private Equity.SK chemicals' business divisions are divided into green chemicals, which produces eco-f
A research team at the Catholic University of Korea College of Medicine has recently identified a protein called Nuclear Receptor Coactivator 6 (NCOA6) as a potential inducer of gouty arthritis in joint macrophages, the primary cells responsible for innate immunity.The team, led by Professor Kim Wan
In a bid to address the looming crisis facing Korea's stroke treatment system, Korean Stroke Society (KSS) held a press conference at the Westin Josun Seoul aimed to dissect the current state of stroke care in the country and propose strategies to strengthen the healthcare infrastructure, especially
A study by researchers at Seoul National University Bundang Hospital (SNUBH) showed that the use of digital healthcare among older adults is poor, with half of the participants unable to install related applications despite smartphone use.Digital healthcare technology, including a wide range of heal
In a notable legal development, Hugel has secured a favorable outcome in its legal battles against the Ministry of Food and Drug Safety (MFDS) regarding the indirect export of Botulax, its botulinum toxin (BTX) products, which led to the revocation of its sales license. The Seoul Administrative Cour
Samsung Biologics said it has obtained the "Leadership A-"grade, the second highest of the eight grades, from Carbon Disclosure Project (CDP), a global sustainability assessment organization, for its climate change response efforts in 2023.The company stressed that it is the first in the domestic bi
Handok said it decided to establish a local joint venture with Swedish Orphan Biovitrum (Sobi), a global biopharmaceutical company specializing in rare diseases, in the first half of this year.Sobi is a global biopharmaceutical company specializing in rare diseases, providing innovative treatments i
Hugel said it showcased new clinical findings for its botulinum toxin (BTX) product at the 25th International Master Course on Aging Science (IMCAS) World Congress, held in Paris, France, from Feb. 1 to 3.The event, which is recognized as the world's largest conference on aesthetic plastic surgery,